Pfizer's Abrocitinib Phase III Data Accepted by CDSCO Expert Committee Parthika Patel6 July 2025 10:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs Standard Control Organisation (CDSCO)...
Frequent Flares in Atopic Dermatitis Linked to Higher Anxiety and Depression, Study Finds Medha Baranwal4 July 2025 9:30 PM ISTDenmark: A new study published in Acta Dermato-Venereologica reveals that adults with atopic dermatitis (AD) who experience frequent or unpredictable...
Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic Dermatitis Parthika Patel4 July 2025 3:00 PM ISTNew Delhi: In a recent regulatory development, the Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs...
Antibiotic Exposure Linked to Higher Risk of Childhood Atopic Dermatitis: Study Dr Riya Dave29 Jun 2025 9:00 PM ISTAccording to a recent meta-analysis published in eClinicalMedicine, antibiotic use during pregnancy or in early childhood significantly increases the...
Atopic Dermatitis Linked to Shorter Stature in Young Children, Finds Research Medha Baranwal24 Jun 2025 8:45 PM ISTUSA: Researchers have discovered in a new study that young children with moderate-to-severe atopic dermatitis (AD) tend to be shorter than their...
Pet dogs could combat genetic eczema risk in children, reveals research Dr. Kamal Kant Kohli17 Jun 2025 8:15 PM ISTHaving a dog at home could help to prevent eczema in children who are genetically prone to the condition, a study suggests. Children with a change in...
AI tool enables real-world assessment of eczema severity via smartphone photos, reveals research Dr. Kamal Kant Kohli13 Jun 2025 8:30 PM ISTA team of researchers from Keio University School of Medicine, Kyoto Prefectural University of Medicine, and Teikyo University, in collaboration with...
Sanofi-Regeneron Dupixent data reinforce use in atopic dermatitis patients with skin of color Ruchika Sharma9 Jun 2025 1:12 PM ISTParis: Sanofi has announced that results from the DISCOVER phase 4, single-arm, open-label study assessing Dupixent (dupilumab) in adults and...
Sun Pharma discontinues development of skin disease drug after trials failure Ruchika Sharma4 Jun 2025 12:27 PM ISTMumbai: Sun Pharmaceutical Industries Limited has announced the discontinuation of two clinical trials evaluating SCD-044, a novel, orally...
Upadacitinib exhibits Efficacy and High Retention in Atopic Dermatitis Treatment, reveals study Dr Riya Dave19 May 2025 9:00 PM ISTReal-world data from Australian patients show that upadacitinib demonstrates strong efficacy in treating atopic dermatitis, with a high treatment...
Phase 3 Trial Backs Ivarmacitinib as Effective Oral Option for Moderate to Severe Atopic Dermatitis Medha Baranwal1 May 2025 9:15 PM ISTChina: A recent phase 3 randomized clinical trial has shown that ivarmacitinib significantly improves symptoms in adolescents and adults with moderate...
Bubbly idea: Ultrafine bubble showers suppress atopic dermatitis Dr. Kamal Kant Kohli29 April 2025 8:30 PM ISTBubble baths might be soothing soaks, but bubble showers could be the next thing in keeping the skin clean. An Osaka Metropolitan University-led...
